NASCAR O'Reilly Auto Parts Series: Top DFS Picks and Betting Insights at Las Vegas Motor Speedway - RotoWire
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
The top DFS picks and best bets for the Focused Health 302 at Las Vegas Motor Speedway, including why Dan Marcus is targeting Austin Hill in NASCAR O'Reilly Series DFS contests on DraftKings.
Focused Health 302Location: Las Vegas, Nevada Course: Las Vegas Motor SpeedwayFormat: Tri-OvalLength: 1.5 milesLaps: 201NASCAR O'Reilly Series Race Preview Sheldon Creed has doubled his career win total in the O'Reilly Series since The Chase began, as he took the checkered flag for the second time in the last three races at Bristol two weeks ago. Creed's hot start, combined with relatively poor results from Justin Allgaier, have already led to him being atop The Chase standings. Allgaier, Carson Kvapil and even Jesse Love are all still within reasonable striking distance, so there will be a compelling final six races down the stretch of the season.
This article is an excerpt. To read the full content, visit the original source. RotoWire
Related articles
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!